Beta-lactam antibiotics as a possible novel therapy for managing epilepsy and autism, a case report and review of literature


Autoria(s): Ghanizadeh, A.; Berk, M.
Data(s)

01/12/2015

Resumo

Autism is a disorder of unknown etiology. There are few FDA approved medications for treating autism. Co-occurring autism and epilepsy is common, and glutamate antagonists improve some symptoms of autism. Ceftriaxone, a beta-lactam antibiotic, increases the expression of the glutamate transporter 1 which decreases extracellular glutamate levels. It is hypothesized that modulating astrocyte glutamate transporter expression by ceftriaxone or cefixime might improve some symptoms of autism. This case report of a child with autism and epilepsy suggests a decrease in seizures after taking cefixime

Identificador

http://hdl.handle.net/10536/DRO/DU:30070215

Idioma(s)

eng

Publicador

Iranian Child Neurology Society

Relação

http://dro.deakin.edu.au/eserv/DU:30070215/berk-betalactam-2015.pdf

Direitos

2015, Iranian Child Neurology Society

Palavras-Chave #Antibiotic #Cefixime #Glutamate #Inflammation #Therapy #Transporter
Tipo

Journal Article